Thus, our study establishes a novel animal model for studying large EVs derived from malignant cells and provides insights into how STING signalling propagates from tumour cells to the immune system via large EV biogenesis, inducing a systemic immune response to tumours. This evidence concerns the gene STING1 and neoplasm.